Butterfly Network, Inc.

Butterfly Network, Inc. develops handheld ultrasound systems built around its proprietary Ultrasound-on-Chip semiconductor technology, which replaces traditional piezoelectric crystal-based designs. The company sells the Butterfly iQ3, iQ+, iQ+ Bladder, Butterfly Move, and veterinary probes together with software subscriptions, cloud tools, education products, and professional services. Its business is designed to make point-of-care imaging portable and easier to use across hospitals, clinics, emergency services, home care, and global health settings. Butterfly also has a growing embedded-technology and licensing element, where it supplies semiconductor chips and software support to partners. The company was founded in 2011 and now sells in more than 30 countries through direct sales, distributors, and eCommerce.

−81,7 %

46,9 %

−79,0 %

+19,0 %

3.83

2.88

— Butterfly Network, Inc.
%
Ultrasound devices65% Handheld ultrasound probes and related accessories used for point-of-care imaging in human and veterinary care.
Software subscriptions and cloud services25% SaaS, support, teleguidance, and cloud-hosted workflow tools sold to healthcare customers.
Education and training5% Butterfly Academy, Certified courses, and in-app educational content that help users adopt and use the devices.
Butterfly Embedded and licensing5% Semiconductor chip deliveries, SDKs, and partnership support services tied to co-development and licensing.

Butterfly sells primarily to healthcare systems, physicians, and healthcare providers that want portable ultrasound at...

  • Hospital and health system enterprisesprimary

    Buy probes, software subscriptions, and deployment services to standardize point-of-care ultrasound across departments and clinicians.

  • Individual physicians and cliniciansprimary

    Purchase devices through direct sales or eCommerce because the handheld form factor makes ultrasound accessible outside traditional imaging departments.

  • Out-of-hospital care providerssecondary

    Clinics, EMS, urgent care, and home-care teams buy portable imaging tools to support diagnosis and monitoring at the bedside or in the field.

  • Veterinary customerssecondary

    Buy Butterfly iQ+/iQ3 Vet devices for animal imaging and workflow support in veterinary practices.

  • Global health and NGO partnersemerging

    Use donated or deployed devices in underserved communities where access to imaging is limited.

  • Embedded technology partnersemerging

    License semiconductor chips and software support for co-development and integration into partner products.

Butterfly is headquartered in Burlington, Massachusetts and operates through subsidiaries in the United States,...

  • Headquartered in Burlington, Massachusetts, with global operating subsidiaries
  • Direct sales in Germany and the United Kingdom
  • Commercial footprint in approximately 40 countries
  • Products sold in over 30 countries through direct, distributor, and eCommerce channels
  • Devices used in over 100 countries through NGOs and global health partners
  • Low-resource settings are an important non-commercial deployment channel

Butterfly’s strategy is to deepen penetration in core point-of-care ultrasound by expanding from individual users into...

01
Enterprise hospital penetrationshort-term

Large health systems can standardize usage across many clinicians and create durable device, software, and support demand.

02
Out-of-hospital and home-care expansionmedium-term

Portable ultrasound can move imaging closer to the patient and support lower-cost care pathways outside traditional radiology settings.

03
Butterfly Embedded monetizationmedium-term

Licensing and co-development can extend the semiconductor platform into new revenue streams beyond probe sales.

04
Education and workflow adoptionshort-term

Training lowers the barrier to ultrasound use for clinicians without prior imaging expertise and supports repeat usage.

Butterfly remains exposed to the risk that adoption of handheld ultrasound grows more slowly than expected, especially...

high

Cybersecurity breach of products or IT systems

Devices connect to customer IT environments and cloud services, so a breach could disrupt care, expose PHI, and trigger recalls or litigation.

Scope
Installed base, cloud software, and third-party hosted services
Materiality
high
high

Supplier disruption or third-party component failure

The company relies on external hardware and software inputs, and a supplier incident could affect production or product functionality.

Scope
Manufacturing and product supply chain
Materiality
high
high

Continued operating losses and capital needs

Butterfly has a limited revenue base relative to its commercialization and R&D ambitions, so funding needs can remain elevated.

Scope
Corporate liquidity and growth investment
Materiality
high
medium

Regulatory and market authorization risk

Medical device sales depend on maintaining FDA, CE, and other approvals in each market.

Scope
U.S., Europe, and international commercialization
Materiality
high
medium

Adoption and reimbursement uncertainty

The value proposition depends on clinicians changing workflows and payors or providers recognizing cost savings.

Scope
Hospital, outpatient, and home-care adoption
Materiality
high
Revenue recognition for bundled device and software contracts
Revenue timing and deferred revenue balances
Point-in-time versus over-time recognition
Quarterly comparability and revenue mix
Quarterly volatility from device sales timing
Reported growth rates and margin trends
Estimates and judgments in contract allocation
Revenue deferral and recognized margin

: 11/08/2026